Dongfeng Qu

Title: The Innovations of Dongfeng Qu

Introduction

Dongfeng Qu is a notable inventor based in Edmond, OK (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies related to the DCLK1 protein. With a total of 2 patents, his work has implications for various medical applications.

Latest Patents

Dongfeng Qu's latest patents include "Anti-doublecortin-like kinase 1 antibodies and methods of use" and "Anti-DCLK1 monoclonal antibodies and methods of production and use thereof." The first patent discloses antibodies and antigen-binding fragments that specifically bind to the human DCLK1 protein. It also covers hybridomas or other cell lines that express these antibodies, along with nucleic acids, vectors, and host cells that encode such antibodies. In certain embodiments, these antibodies specifically target an epitope within isoform 2 or 4 of the DCLK1 protein. The second patent focuses on monoclonal antibodies against DCLK1 and their conjugates, detailing methods for their production and use.

Career Highlights

Dongfeng Qu is affiliated with the University of Oklahoma, where he conducts his research and development work. His innovative approaches in biotechnology have positioned him as a key figure in his field.

Collaborations

He has collaborated with notable colleagues, including Courtney W. Houchen and Randal May, contributing to the advancement of research in their shared areas of expertise.

Conclusion

Dongfeng Qu's contributions to the field of biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical science.